The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma
The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma
复制标题
DOI:
10.1016/s0959-8049(01)00273-8
复制
发表时间:
2001-11-01
影响因子:
8.4
通讯作者:
Lock, RB
中科院分区:
文献类型:
--
作者:
Catchpoole, DR;Lock, RB
The clinical aggressiveness of neuroblastoma, a childhood embryonal tumour of neuroectodermal cells derived from the neural crest, is considered to be dictated by the competitive interactions between cell proliferation, differentiation and apoptosis. Caspase-9 is a central effector enzyme in the apoptotic mechanism. Recent studies with caspase-9 (CASP9) knockout mice indicate a primary defect in the brain caused by decreased apoptosis during the early stages of nervous system development. It is our hypothesis that silencing of CASP9 through genetic mutations may promote neuroblastoma tumorigenesis. Here, we report the outcome of screening neuroblastoma tumours for silencing mutations in CASP9. cDNA prepared from RNA isolated from 22 neuroblastoma tumours representing the full range of neuroblastoma clinicopathological disease stages was sequenced. Single nucleotide changes were detected in all neuroblastoma tumours, but were found not to represent silencing mutations, but rather sequence polymorphisms. These polymorphisms did not associate with the clinicopathological stages or disease or the predicted clinical outcomes of the patients. Silencing mutations of CASP9 are therefore unlikely to be causal to neuroblastoma tumorigenesis. (C) 2001 Elsevier Science Ltd. All rights reserved.